Computational Analysis and Prediction of the Binding Motif and Protein Interacting Partners of the Abl SH3 Domain by Hou, Tingjun et al.
Computational Analysis and Prediction
of the Binding Motif and Protein Interacting
Partners of the Abl SH3 Domain
Tingjun Hou
1,2, Ken Chen
1,2, William A. McLaughlin
1,2, Benzhuo Lu
1,2, Wei Wang
1,2*
1 Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, California, United States of America, 2 Center for Theoretical Biological Physics,
University of California San Diego, La Jolla, California, United States of America
Protein-protein interactions, particularly weak and transient ones, are often mediated by peptide recognition domains,
such as Src Homology 2 and 3 (SH2 and SH3) domains, which bind to specific sequence and structural motifs. It is
important but challenging to determine the binding specificity of these domains accurately and to predict their
physiological interacting partners. In this study, the interactions between 35 peptide ligands (15 binders and 20 non-
binders) and the Abl SH3 domain were analyzed using molecular dynamics simulation and the Molecular Mechanics/
Poisson-Boltzmann Solvent Area method. The calculated binding free energies correlated well with the rank order of
the binding peptides and clearly distinguished binders from non-binders. Free energy component analysis revealed
that the van der Waals interactions dictate the binding strength of peptides, whereas the binding specificity is
determined by the electrostatic interaction and the polar contribution of desolvation. The binding motif of the Abl SH3
domain was then determined by a virtual mutagenesis method, which mutates the residue at each position of the
template peptide relative to all other 19 amino acids and calculates the binding free energy difference between the
template and the mutated peptides using the Molecular Mechanics/Poisson-Boltzmann Solvent Area method. A single
position mutation free energy profile was thus established and used as a scoring matrix to search peptides recognized
by the Abl SH3 domain in the human genome. Our approach successfully picked ten out of 13 experimentally
determined binding partners of the Abl SH3 domain among the top 600 candidates from the 218,540 decapeptides
with the PXXP motif in the SWISS-PROT database. We expect that this physical-principle based method can be applied
to other protein domains as well.
Citation: Hou T, Chen K, McLaughlin WA, Lu B, Wang W (2006) Computational analysis and prediction of the binding motif and protein interacting partners of the Abl SH3
domain. PLoS Comput Biol 2(1): e1.
Introduction
The interactions between protein domains and their
peptide ligands play critical roles in signal transduction and
many other key biological processes. Because domain-peptide
interactions are usually weak and transient, and often depend
upon post-translational modiﬁcation, they tend to be under-
represented in high-throughput and computational studies
[1], thus highlighting the need to develop new methods to
identify these interactions. The Src Homology 3 (SH3)
domain is the most abundant modular domain in the human
proteome and presents in a wide variety of proteins, such as
kinases, lipases, GTPases, and adaptor proteins, to orchestrate
diverse cellular processes [2–6]. SH3 domains are 50–70
amino acids long and consist of ﬁve b-strands arranged into
two sheets packed at right angles. They recognize the proline-
rich peptides with the consensus motif PXXP (where P is
proline and X is any amino acid) [7, 8] that forms a left-
handed poly-proline type II (PPII) helix [9]. Depending on the
position of the positive residue in the peptide sequence, the
majority of SH3 ligands fall into two classes that bind to the
protein in opposite orientations [10]: N-terminal to C-
terminal (class I) or C-terminal to N-terminal (class II). Class
I peptides typically consist of a core motif of RXLPX#P
(where # is usually a hydrophobic residue), whereas the class II
peptides contain a core motif of PX#PXR. In class I peptides,
the proline residues in bold occupy the sites in the hydro-
phobic pocket that are normally referred as position P0 and
P3, while the Arg residue occupies position P 3 (the positions
are often dubbed as P 3,P  2,P  1,P 0,P 1,P 2, and P3 from N-
terminal to C-terminal, namely from R to P, in the motif
RXLPX#P [2]). A notable variance of this motif is the one
recognized by the Abl SH3 domain, which contains a tyrosine
or a large hydrophobic residue at position P 3.
The binding speciﬁcity of a speciﬁc SH3 domain is
determined by the ﬂanking residues around the core motif
PXXP [10]. Understanding the molecular basis of the
speciﬁcity for each SH3 domain and identifying the sequence
motif it recognizes are crucial to reconstruct the complete
protein-protein interaction networks mediated by SH3
domains. Both experimental and computational methods
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screening is often used to determine the binding motif of a
SH3 domain, in which the binding peptides are sequenced
and aligned to generate a frequency matrix representing the
amino acid preference at each position [11, 12]. Bias may be
introduced by not completely sampling all possible peptides,
not quantitatively weighting the contribution of peptides to
the matrix based on their binding strength and/or not
distinguishing peptides bound to the SH3 domain in differ-
ent binding modes. Computational methods such as Scansite
[13], SPOT [14], and VIP [15] methods have been developed to
predict interacting proteins of a domain. The performance of
Scansite totally depends on the accuracy of the frequency
matrix determined by the peptide library experiments. SPOT
is limited by the relatively small number of residue contact
pairs between SH3 domains and peptides. The performance
of the VIP method can be improved if more conformational
sampling is done and more rigorous binding energy
prediction method, including the conformational energy
change and the desolvation contribution upon peptide
binding, is applied.
In this study, we analyzed the binding speciﬁcity of the SH3
domain of the human protein Abl. The Molecular Mechanics/
Poisson-Boltzmann Solvent Area (MM/PBSA) method [16] was
ﬁrst applied to calculate the binding free energies between
the Abl SH3 domains and 35 ten-residue-long peptides (15
binders and 20 non-binders). As a validation of the MM/PBSA
method on the domain-peptide system, the calculated bind-
ing free energies of the 15 known binders correlated well with
the experimental values [17] and were distinct from those of
the non-binders. Analysis of the molecular dynamics (MD)
trajectories and binding free energy components shed light
into understanding the mechanism of the binding speciﬁcity
of the Abl SH3 domain. The residue preference at each
position of the peptide ligand was then studied systematically
by single position mutation and MM/PBSA calculations,
which we call the virtual mutagenesis (VM) method [18, 19].
A single position mutation free energy proﬁle (SPMFEP) was
established from such analysis to quantitatively represent the
binding motif and was in good agreement with the
experimental measurements. We used SPMFEP as a scoring
matrix to search the SWISS-PROT database for potential
binding partners of the Abl SH3 domain. Most experimen-
tally determined binding proteins of the Abl SH3 domain
were ranked in the top 600 candidates among about 6.2310
7
decapeptides in the database and many promising candidates
were also suggested.
Results
Molecular Basis of the Binding Specificity of the Abl SH3
Domain
The calculated binding free energies correlate well with the
experimental values. We ﬁrst evaluated the performance of
the MM/PBSA method on calculating the binding free
energies of the Abl SH3 domain and its peptide ligands (15
binders and 20 non-binders). As shown in Table 1 and Figure
1, the calculated relative binding free energies of the 15
known binders show good correlation with the experimental
values (the correlation coefﬁcient r and standard deviation
[SD] are 0.82 and 1.7, respectively). We then analyzed the free
energy components to search for the dominant factor that
dictates the binding speciﬁcity (Table 1). As the favorable
electrostatic interaction between the peptide and the SH3
domain DEele is canceled by the unfavorable electrostatic
contribution to desolvation DGPB,t h ev a nd e rW a a l s
interaction DEvdw is the most favorable component of the
binding free energy. The favorable DEvdw is mainly from the
interactions between the conserved proline residues of the
PXXP motif and the hydrophobic surface that is formed by
Tyr7, Phe9, Trp36, Tyr52, and Pro49 of the Abl SH3 domain
and conserved in almost all SH3 domains. To investigate
which energetic factor determines the relative binding
afﬁnities of these 15 binders, we compared the correlations
between the measured binding free energies and each of the
four free energy components, DEele, DEvdw, DGPB, and DGSA.
None of these components shows good correlation with the
experimental values and the largest correlation coefﬁcient is
only 0.43 for DEele, which suggests that no individual free
energy component dominates the binding speciﬁcity. We
then analyzed the non-polar (DEvdw þ DGSA) and the electro-
static contribution (DEeleþ DGPB) to the binding free energy.
The electrostatic contribution correlates well with the bind-
ing free energies (r ¼ 0.73, SD ¼ 1.6) while the non-polar
contribution does not show any correlation (r ¼  0.32, SD ¼
2.0). It suggests that the binding preference of these peptides
is mainly determined by the electrostatic contribution to
binding.
We also found that the conformational change of the
peptide upon binding DEconf_pep was important (r¼0.54, SD
¼1.8). The sum of DEele, DEvdw, DGPB, DGSA, and DEconf_pep
correlates well with the binding free energies (r ¼ 0.79, SD
¼1.8) whereas the sum of the ﬁrst four terms does not (r ¼
0.52). Our calculations highlight the crucial effect of the
change of the conformational energy of peptide to the
afﬁnities, which is not always appropriately considered [20,
21]. Inclusion of the conformational entropy TDS in the free
energy calculation only slightly improves the correlation
coefﬁcient from 0.79–0.82, which suggests that the conforma-
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Synopsis
One of the central questions of molecular biology is to understand
how signals are transduced in the cell. Intracellular signal trans-
duction is mainly achieved through cascades of protein-protein
interactions, which are often mediated by peptide-binding modular
domains, such as Src Homology 2 and 3 (SH2 and SH3). Each family
of these domains binds to peptides with specific sequence and
structural characteristics. To reconstruct the protein-protein inter-
action networks mediated by modular domains, one must identify
the peptide motifs recognized by these domains and understand
the mechanism of binding specificity. These questions are challeng-
ing because the domain-peptide interactions are usually weak and
transient. Here, the authors took a physical-principles approach to
address these difficult questions for the SH3 domain of human
protein Abl, which binds to peptides containing the PXXP motif
(where P is proline and X is any amino acid). They generated a
position-specific scoring matrix to represent the binding motif of the
Abl SH3 domain. Analysis on the binding free energy components
suggested insights into how the binding specificity is achieved.
Most known protein interacting partners of the Abl SH3 domain
were correctly identified using the position-specific scoring matrix,
and other potential interacting partners were also suggested.
Prediction of Abl SH3 Binding Partnerstional entropy is not the determinant factor of the binding
speciﬁcity of the binders.
The binding free energies and the free energy components
for the 20 non-binders of the Abl SH3 domain were also
calculated (Table S1). Two distributions of the binding free
energies for binders and non-binders are distinct (Figure 2),
which indicates that the MM/PBSA method can distinguish
binders from non-binders. We also found that most non-
binders preferred unbound conformations. First, the average
conformational entropy change upon binding  TDS for
binders and non-binders are 32.1 kcal/mol and 35.9 kcal/
mol, respectively, indicating that most non-binders lost more
entropy upon binding than did binders. Second, the change
of conformational energy for binders and non-binders are
also signiﬁcantly different: the average value for binders and
non-binders are 2.0 kcal/mol and 4.3 kcal/mol, respectively.
The binding motif can be revealed by the VM method. To
understand the mechanism of the binding speciﬁcity, we need
to determine the binding motif of the domain. We analyzed
the amino acid preference at each position of the peptide
using the VM method (see Materials and Methods). We
compared our results with the available experimental
measurements at positions P3,P 0,P  3, and P 5 (Tables S3–
S6) [17, 22]. These four positions are particularly important
for the peptide binding: the two usually conserved Pro
residues at P3 and P0 ensure strong binding afﬁnity and
Figure 1. The Correlations between Experimental and Predicted Relative
Binding Free Energies of the 15 Binders of the Abl SH3 Domain
DOI: 10.1371/journal.pcbi.0020001.g001
Figure 2. The Distributions of the Predicted Binding Free Energies for
Binders and Non-Binders of the Abl SH3 Domain
DOI: 10.1371/journal.pcbi.0020001.g002
Table 1. Energetic Components and Binding Affinities for the 15 Peptide Ligands of the Abl SH3 Domain (kcal/mol)
Number Sequence DGexp DDGexp DEele DEvdw DGSA DGPB TDSG lig_bound Glig_unbound DGpred
a DDGpred
A1 APSYSPPPPP  7.94 0.00  92.0 6 3.4  49.6 6 0.4  5.3 6 0.0 112.5 6 2.9  31.2 6 0.2  17.8 6 0.6  18.3 6 1.5  2.6 6 0.8 0.0
A2 APTMPPPLPP  6.17 1.77  71.4 6 4.9  49.5 6 0.4  5.4 6 0.1 92.7 6 5.1  33.6 6 0.3  33.2 6 0.8  36.2 6 0.9 2.9 6 0.2 5.5
A3 PPAYPPPPVP  7.23 0.71  83.2 6 3.6  50.8 6 0.5  5.4 6 0.0 101.5 6 2.6  31.8 6 0.1 85.5 6 0.7 83.9 6 0.3  4.5 6 1.0  1.9
A4 FGTYPPPLPP  7.03 0.91  70.3 6 7.3  49.9 6 0.2  5.6 6 0.0 89.7 6 7.6  33.0 6 0.3  41.8 6 0.4  42.2 6 1.3  2.6 6 0.5  0.1
A5 SPSYSPPPPP  7.83 0.11  100.0 6 3.6  48.2 6 1.0  5.2 6 0.0 119.4 6 2.8  31.9 6 0.1  43.6 6 1.1  43.0 6 0.9  3.0 6 0.8  0.4
A6 APTYSPPPPP  8.72  0.78  103.2 6 18.9  50.2 6 1.6  5.4 6 0.1 122.0 6 16.4  31.1 6 0.4  53.9 6 1.7  55.7 6 0.8  4.0 6 1.6  1.4
A7 APTMSPPLPP  6.37 1.57  80.8 6 8.3  50.6 6 0.8  5.3 6 0.0 103.5 6 9.0  33.8 6 0.3  63.9 6 2.9  64.7 6 2.6 1.5 6 0.6 4.0
A8 APTYPPPLNP  5.48 2.46  97.6 6 8.0  51.3 6 0.5  5.5 6 0.0 118.7 6 6.7  31.6 6 0.4  90.4 6 1.6  95.2 6 0.1 0.8 6 1.3 3.4
A9 APTYHPPLPP  5.30 2.64  75.2 6 1.4  51.2 6 0.5  5.4 6 0.0 99.4 6 1.5  30.9 6 0.1  28.3 6 2.2  32.7 6 1.4 2.9 6 0.7 5.5
A10 APTMPPPPPP  6.95 0.99  80.8 6 5.0  48.9 6 0.6  5.3 6 0.0 99.6 6 4.9  33.4 6 0.4  33.8 6 1.6  34.1 6 0.2  1.8 6 0.6 0.8
A11 APTYPPPLPH  6.23 1.71  83.7 6 4.2  53.6 6 0.7  5.7 6 0.0 107.4 6 3.6  32.0 6 0.2  39.7 6 3.6  45.3 6 0.9 2.0 6 0.8 4.6
A12 APTYPPPLPL  6.17 1.77  87.7 6 6.7  51.8 6 0.4  5.5 6 0.1 112.2 6 6.2  31.3 6 0.4  62.3 6 2.1  65.8 6 0.3 1.9 6 0.1 4.4
A13 APTYPPPPPP  7.36 0.58  93.8 6 7.2  50.2 6 0.5  5.3 6 0.1 113.4 6 6.9  31.4 6 0.2  31.8 6 0.9  31.8 6 1.3  4.5 6 0.3  2.0
A14 APTYSPPLPP  7.23 0.71  90.1 6 9.6  51.2 6 0.3  5.5 6 0.1 112.2 6 9.6  32.2 6 0.0  56.7 6 1.2  59.5 6 1.1 0.5 6 0.3 3.1
A15 ALPYPPPLPP  5.93 2.01  95.1 6 1.2  45.7 6 0.1  5.1 6 0.0 116.5 6 1.8  32.9 6 0.4 24.3 6 0.9 24.9 6 1.8 2.6 6 0.8 5.2
DDGexp is the difference between the experimental binding free energies of each peptide and the template peptide APSYSPPPPP; DEele and DEvdw are the electrostatic interaction and van der Waals interaction between the peptide and the
Abl SH3 domain, respectively; DGSA and DGPB are the non-polar and polar contributions of the solvation free energy upon peptide binding, respectively; Glig_bound and Glig_unbound are the conformational energy of peptide in the bound and un-
bound states, respectively; DGpred is the predicted binding free energy; DDGpred is the difference between the predicted binding free energy of each peptide and the template peptide APSYSPPPPP.
aStandard deviations are estimated from three block average values.
DOI: 10.1371/journal.pcbi.0020001.t001
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Prediction of Abl SH3 Binding Partnersresidues at P 3, and P 5 are essential to the binding speciﬁcity
[9, 10]. To determine the residues of the Abl SH3 domain that
are important for peptide binding, the contribution of each
SH3 domain residue to binding with the template peptide
APSYSPPPPP (the two conserved Pro residues are in bold)
was analyzed (the polar contribution to desolvation was
calculated using the GB/SA method implemented in the
mm_pbsa module of AMBER 8 for the sake of efﬁciency.)
(Table S7) [19].
In the crystal structure of APSYSPPPPP complexed with
the Abl SH3 domain, the residue at position P 5 in the
peptide occupies a hydrophobic pocket of the SH3 domain.
Proline at this position has relatively strong van der Waals
interactions with Trp36 ( 1.3 kcal/mol) and Trp47 ( 0.9 kcal/
mol) in the Abl SH3 domain (Table S7). Several other
residues, Asn, Leu, Met, Phe, Tyr, and Val, are also strongly
favored at this position (Figure 3A). It is worth pointing out
that the mutation of Pro to Tyr or Phe, does not signiﬁcantly
impair the van der Waals interaction between the peptide
and the SH3 domain due to the conformational change of the
peptide backbone. Our predicted preference based on free
energy calculations is consistent with the experimental
results: Pro is the most preferred, whereas other residues
especially hydrophobic ones (Phe, Leu, Met, Val, and Trp) are
also favored [22].
It should be noted that the preference of residue at P 5 are
closely related to the residues at the adjacent positions. For
example, the known binder FGTYPPPLPP (A4 in Table 1) has
a Gly at P 5, which is not favored at this position based on the
VM result. By analyzing the MD trajectory on A4-SH3
complex, we found that Phe at P 6 in A4 can occupy the
binding pocket that is occupied by Pro at P 5 in the template
peptide APSYSPPPPP to form favorable van der Waals
interactions with Trp36 and Trp47. Moreover, the benzyl
ring of Phe at P 6 is parallel to the aromatic ring of Trp47 to
form strong p-p stacking interactions. Therefore, if there is a
small residue (Ala, Gly, or Ser) at P 5, an aromatic residue
(Tyr, Phe, or Trp) may be preferred at P 6. This suggests that
the repertoire of SH3 domain-binding peptides may be much
larger than previously thought.
Our analysis showed that Trp, Phe, Tyr, Met, and Pro are
favored at P 3 (Figure 3B), which is in good agreement with
the study of Villanueva’s et al. that the most favorable
residues are Trp, Tyr, Phe, and Met (ordered based on the
binding free energies) [22]. This observation is consistent with
ﬁndings that an aromatic residue is favored at P 3 of mouse
protein 3BP1, a known binder of the Abl SH3 domain [12, 23,
24]. The energy component analysis (Table S4) suggests that
the strong preference of these four residues at this position is
mainly due to the favorable non-polar contribution (DEvdw þ
DGSA) upon peptide binding: DEvdwþDGSA for Trp, Tyr, Met,
and Phe are  55.9,  55.4,  54.4, and  53.8 kcal/mol,
respectively, which are stronger than the other 16 residues
at this position. Interestingly, positive charged residues, Arg
and Lys, are not favored at this position, which is in contrast
to most SH3 domain-binding peptides. To investigate the
reason, we have compared the electrostatic surfaces of four
SH3 domains, Abl tyrosine kinase SH3 domain (PDB entry
1bbz) [25], c-Crk N-terminal SH3 domain (PDB entry 1cka)
[26], Grb2 N-terminal SH3 domain (PDB entry 1gbq) [27], and
rat amphiphysin-2 SH3 domain (PDB entry 1bb9) [28] (Figure
4). Electrostatic potentials were calculated by solving the
Poisson-Boltzmann equation using the Delphi program [29]
in Insight II [30]. We ﬁnd that the rat amphiphysin-2 SH3
domain has the largest areas of negative electrostatic
potentials, which is mainly due to the acidic residues in
Arg-Thr and extended n-Src loops of the domain. The large
patch of negative electrostatic potential explains why the
Figure 3. The Preference of Residue Based on the Binding Free Energy Difference between the Mutated Peptide and the Template Peptide
The preference of residue at positions (A) P 5, (B) P 3, (C) P0, and (D) P3 based on the binding free energy difference between the mutated peptide and
the template peptide APSYSPPPPP. In (D), the conformational entropy was included in the binding free energies.
DOI: 10.1371/journal.pcbi.0020001.g003
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Prediction of Abl SH3 Binding Partnersamphiphysin SH3 domain speciﬁcally recognizes the
PXRPXR motif with two positively charged Arg residues.
The c-Crk N-terminal and the Grb2 N-terminal SH3 domain
have distinct but relatively small negative potential near the
Arg-Thr and n-Src loop, which may explain why these two
SH3 domains bind to peptides only possessing a single
positively charged residue. Compared with the other three
SH3 domains, the Abl SH3 domain does not possess
remarkable and continuous distribution of the negative
electrostatic potentials and therefore positively charged
residues are not strongly preferred.
Proline is highly preferred at positions P0 and P3. We ﬁnd
that Pro at P0 has favorable interactions with Phe9 and Tyr52
( 1.0 kcal/mol and  1.0 kcal/mol) (Table S7), as well as
favorable van der Waals interaction with Pro49 ( 0.8 kcal/
mol). Experimental and theoretical studies have focused on
understanding how SH3 domains recognize the core motif
PXXP [31, 32]. Proline is the most favorable residue at this
position based on our free energy calculation (Figure 3C).
When only the non-polar contribution (DEvdw þ DGSA)i s
considered, the peptide with Pro has the strongest interaction
with SH3 ( 54.8 kcal/mol) (Table S5), which agrees with the
study of Wang et al. [31]. In addition to the non-polar
contribution, we found the less unfavorable desolvation-free
energy is also an important factor for the preference of
proline. For example, the residues at P0 in peptides 16, 19,
and 20 (Table S5) all have relatively small side chains (Thr,
Val, and Pro, respectively) and have similar protein-ligand
electrostatic interactions DEele. When the polar contributions
of desolvation-free energies DGPB were considered, the
peptide 20 has the least unfavorable contribution (DEele þ
DGPB ¼þ20.5 kcal/mol). We believe that upon peptide
binding the desolvation cost for the nitrogen-substituted
atom in Pro may be less than that of the non-substituted
nitrogen atom in the other amino acids, because the non-
substituted nitrogen atom can be easily polarized by the
solvent [32].
Proline is also strongly selected at P3 in almost all SH3
domain-binding peptides. From the calculated binding free
energies (Figure 3D), it is interesting to ﬁnd that, although
Pro is preferred at this position by the Abl SH3 domain, the
preference is not very strong. Proline at this position can be
mutated to several other residues including Trp, Phe, Met,
His, Leu, Gln, and Tyr, and the mutated peptides still have
relatively strong binding free energies. Our calculation seems
to contrast with what has been suggested about the critical
role of Pro at P3 in SH3 ligands [10]. However, in the
mutation experiments reported by Pisabarro et al. [17], Pro at
P3 in peptide APTYPPPLPP was mutated to His, Leu, and Tyr,
and the binding afﬁnities of the mutated peptides were only
slightly decreased from  7.1 kcal/mol to  6.2,  6.2, and  6.2
kcal/mol, respectively. These three favorable residues re-
ported by Pisabarro et al. were also relatively favored in our
predictions.
Identifying Physiological Interacting Partners of the Abl
SH3 Domain
Based on the comparison between the experimental and
calculated results, we have shown that the VM method can
determine the binding motif of the Abl SH3 domain. The
difference between the binding free energies of the mutated
peptide at each position and the template peptide AP-
SYSPPPPP, called SPMFEP, can be used as a position speciﬁc
scoring matrix to predict the binding afﬁnities of peptides
(Table 2). To evaluate the performance of SPMFEP, the 15
binders and 20 non-binders were ﬁrst scored using SPMFEP.
Two obvious distributions for binders and non-binders can
be observed (Figure 5), indicating that binders and non-
binders can be successfully distinguished by SPMFEP. The
binding afﬁnity of peptide A4 was under-estimated. From our
analysis (see above), we know that Phe at P 6 in the peptide
A4 is favorable in the hydrophobic binding pocket that is
originally occupied by Pro at P 5 in the template peptide.
Consequently, the residues at P 6 and P 5 may interact with
each other. In SPMFEP, the inter-dependence between
positions is not considered. In fact, all methods using a
position speciﬁc scoring matrix, such as Scansite [13], have
the same limitations. Overall, SPMFEP performs well on the
selected 35 peptides.
We next scanned the SWISS-PROT using SPMFEP to
predict interacting partners of the Abl SH3 domain. There
are about 6.2 3 10
7 ten-residue-long peptides in the current
SWISS-PROT database (May 2005), in which about 218,540
ten-residue-long peptides have the PXXP motif. Only about
2,600 peptides have scores smaller than two, which are in the
top 0.005% (the top 600 peptide sequences in 353 unique
human proteins are listed in Table S9). We ﬁrst carefully
examined the top ten candidates in the human proteome
(Table 3), among which WASF1 and EVL are known
Figure 4. The Electrostatic Potentials of the Peptide-Binding Interfaces
for Four SH3 Domains
(A) 1bbz, (B) 1cka, (C) 1gbq, and (D) 1bb9.
The scale of gradation was from 5 kT/e toþ5 kT/e corresponding to red
color to blue color. The electrostatic potentials of proteins were
calculated using the Delphi module in Insight II. The salt concentration
was set to 0.0 M because electrostatic potentials had small changes in
the range of the experimental salt concentrations. The internal and
external dielectric constants were set to 1 and 80, respectively.
Electrostatic potentials were computed using a grid space of 0.5 A ˚ with
the focusing technique. The structures of the four SH3 domains were
aligned using the Homology module in Insight II. The Tyr residue at P 3
in peptide APSYSPPPPP was shown in stick.
DOI: 10.1371/journal.pcbi.0020001.g004
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Prediction of Abl SH3 Binding Partnersinteracting partners of the Abl SH3 domain [33, 34]. WASF4
is a homology of WASF1 and is in the same protein family.
SEM6A is a homology of the mouse protein SEM6D, a known
Abl SH3 domain-binding protein, and is therefore likely to be
a true binder [35]. In total, we have identiﬁed two known
binders and two candidates highly supported by experimental
evidence, among the top ten peptides, which is a surprisingly
good result. As a comparison, the top ten human peptides in
the Scansite search are [13] 3BP2, RX, RBMG, TACT, PRL3,
SCA3, AT19, AD08, DYN2, and SEP4, among which only
3BP2, the homology of a known binder (mouse protein 3BP2),
is likely to be a true binder [36] but no binding information is
found for all other candidates in BIND [36] and MINT [37]
databases to interact with Abl protein or the Abl SH3
domain. If only considering the top ten candidates, the
SPMFEP method based on VM performs better than Scansite
on identifying the interacting partners of the Abl SH3
domain.
In MINT [37] and BIND [36], 44 non-redundant proteins
have been identiﬁed to directly interact with the protein Abl,
and 13 of them, including ﬁve mouse proteins and eight
human proteins, bind to the Abl SH3 domain. We compared
the performance of SPMFEP, Scansite [13], and iSPOT [14], to
identify these 13 proteins (Table 4). The top 600 candidates
found in human proteins and the top 2,000 candidates found
in all proteins were saved for further analyses.
SPMFEP can successfully identify ten known binders: seven
of the eight human proteins and three of the ﬁve mouse
proteins (Table 4 and Table S8). 3BP1_mouse and
3BP2_mouse are not ranked highly, considering all proteins
(1,393 and 1,895) but they are in the top 500 if only mouse
proteins are considered. The human homologies of
3BP1_mouse and 3BP2_mouse are in the top 600 candi-
dates (249 for 3BP1_human and 502 for 3BP2_human)
(Table S9) and it is reasonable to believe that they are true
binders of the Abl SH3 domain. Overall, we have successfully
identiﬁed most of the known binders of the Abl SH3 domain.
Scansite can identify eight known binders of the Abl SH3
domain (Table 4). P73_human, not identiﬁed by SPMFEP, is
ranked 321 in the Scansite result. Agami et al. [38] reported
that a P73 mutant P338A could not form stable P73-Abl
complexes. If P73 interacts with Abl by ten-residue-long
peptide segment, this peptide segment should be AFKQSP-
PAVP, which is the same as the peptide identiﬁed by Scansite.
Based on our VM analysis and mutation experiments by
Pisabarro and Serrano [17], Phe at P 5 and Lys at P 4 are not
favored. Because Scansite considers 15-residue-long peptides
rather than ten-residue-long peptides in SPMFEP, it is likely
that the ﬁve additional residues may contribute favorably to
binding. It is not surprising that the longer the peptide, the
more speciﬁc, but less sensitive, are the predictions.
Using iSPOT, we can only correctly identify ﬁve binders
(Table 4). In iSPOT, the scoring matrix was derived from
position-speciﬁc contacts based on six SH3-peptide or SH3-
protein complex structures [14]. The accuracy of the matrix is
limited by the relatively small number of residue-resident
contacts found between SH3 domains and their binding
peptides to ﬁll the 27310310310 position-speciﬁc contact
matrix.
CABL2_human and SEM6D_mouse (Table 4) cannot be
identiﬁed by all the three methods. Experiments [35, 39] have
shown that their interactions with Abl are mediated by the
interaction between the proline-rich region and the Abl SH3
domain. Since the scoring matrix used by all the three
methods does not consider dependence between positions,
we suspect that synergistic interactions may exist between
positions within or beyond the proline-rich regions of the
two proteins.
Discussion
In this study, we have demonstrated that the MM/PBSA
method can accurately calculate the binding free energies
between the Abl SH3 domain and its peptide ligands.
Table 2. SPMFEPs of the Abl SH3 Domain
Residue Position
P 6
a P 5 P 4 P 3 P 2 P 1 P0 P1 P2 P3
A 0.0 6.4 0.0 6.7 0.0 5.4 6.3  0.4 2.6 1.8
R 4.0 7.4 13.6 9.1 3.50 7.4 17.2 8.6 8.8 15.0
N 2.0 2.9 1.4 2.3 0.8 5.2 6.2 6.6 5.0 3.3
D 4.0 20.9 4.2 16.4 12.3 18.8 11.4  0.5 2.3 15.0
C 0.0 4.4  0.4 1.6  0.5 3.4 6.3  0.1 1.9 3.5
Q 0.0 18.4 0.7 3.3 13.6 2.8 11.3 1.2 1.3 1.3
E 4.0 20.7 8.6 12.0 13.7 27.1 14.2 6.6 6.6 10.7
G 0.0 9.3 0.2 3.3 0.6 7.7 6.2 0.9 6.6 11.6
H 0.0 10.7 1.1 3.3 0.7 5.2 4.0 1.9 6.5 1.4
I 0.0 10.8 1.1 1.5 4.3 6.2 6.9 5.4 0.3 5.5
L 0.0 3.5 1.6 1.5 7.6 6.1 7.5 1.0 1.4 3.0
K 4.0 5.3 11.4 9.1 8.1 5.6 21.0 8.6 13.7 15.2
M 0.0 3.3 3.3 0.3 3.1 6.4 4.0 3.8 0.8 0.5
F 0.0 3.3 2.7  1.5 8.6 7.3 7.6 5.4 0.8 0.7
S 0.0 8.8 1.1 5.0 0.1  3.3 9.4  1.5 5.3 6.5
T 0.0 5.2  0.2 3.5  0.9 7.5 4.6 1.0 2.3 5.2
W 0.0 13.6 0.1  2.1 7.4 3.6 1.4 1.9 1.6 1.6
Y 0.0 3.4 4.0 0.0 3.4  2.4 5.8 4.0 1.4 2.5
V 0.0 2.0 0.5 3.3 2.4  2.8 8.5  0.2 1.7 3.8
P 0.0 0.0  0.6 0.9  0.2 0.0 0.0 0.0 0.0 0.0
aGiven the conformational flexibility of the terminal residue at P 6, heuristic penalty scores were assigned: 4.0 to the
most unfavorable residues R, D, E, K at P 6, 2.0 to N, and 0 to other residues.
DOI: 10.1371/journal.pcbi.0020001.t002
Figure 5. The Distribution of the Predicted Binding Free Energies Based
on SPMFEP for Binders and Non-Binders
DOI: 10.1371/journal.pcbi.0020001.g005
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Prediction of Abl SH3 Binding PartnersExamination of each component of the binding free energy
shows that, besides the non-bonded interactions and des-
olvation effect, the change of the conformational energies of
the peptides upon binding is also crucial to determine the
binding speciﬁcity of the domain. These results are encour-
aging to apply MD simulation and free energy calculation to
understand the molecular mechanism of other domain-
peptide and protein-protein interactions.
We have also shown that the VM method can precisely
determine the sequence motif recognized by the Abl SH3
domain. The experimental scheme of the VM method is
totally different from those of the current peptide library
experiments in the following ways: 1) produce all possible
peptides that are one amino acid different from the template
peptide; (2) measure the ‘‘binding’’ afﬁnities of all these
peptides; and, (3) generate a scoring matrix based on the
binding afﬁnity differences between the mutated and the
template peptides to determine the binding motif.
There are advantages of this scheme. First, the preference
of an amino acid is quantitatively measured, based on the
binding afﬁnity of the peptide, which at least partially
overcomes the sampling difﬁculty in the current peptide
library experiment. Ideally, to determine the binding motif of
a domain, one should examine the binding between the
domain and all possible peptides of a given length, and align
all binding peptides to calculate the frequency of each amino
acid occurring at each position. In reality, there are usually
only 10
7–10
10 peptides in the library, due to the limit of time
and cost. If the length of the binding peptide is ten, there are
10
10–10
13 possible peptides and the coverage of the peptide
sequence space by the peptide library is about 10
 6–10
 3.I f
15-residue-long peptides are considered as in Scansite, the
coverage drops dramatically to 10
 12–10
 9. By measuring the
relative preference of every amino acid based on the peptide-
binding afﬁnities, one overcomes this insufﬁcient sampling
issue and mimics the ideal procedure given the position-
independence assumption. Second, the VM method can
evaluate the penalties of unfavorable amino acids even the
peptide do not really bind to the protein, which is very hard if
not impossible in the experimental approaches. Third, since
the scoring matrix is obtained by taking the difference
between the template and the mutated peptides that are only
one amino acid different from the template peptide, some
Table 3. Top Ten Binding Partner Candidates of the Abl SH3 Domain Identified by SPMFEP
Rank Protein Accession ID Start End Peptide Score Scansite Rank
a Protein
1 RW1 Q92545 1521 1530 SPTPASPSPP  4.1 3
b RW1 protein [fragment]
2 WASF4 (SCAR2) Q8IV90 475 484 PPPPSSPSFP  3.6 3
b Wiskott-Aldrich syndrome protein family member 4
3 TREX1 Q9NSU2 107 116 GPPPTVPPPP  3.4 1,194 Three prime repair exonuclease 1
4 ACRO (ACR, ACRS) P10323 344 353 PPPPPSPPPP  3.2 54 Acrosin [precursor]
5 LRRN5 (GAC1) O75325 22 31 VVPWHVPCPP  2.9 3
b Leucine-rich repeats neuronal protein 5 [precursor]
6 SEM6A (SEMA6A) Q9H2E6 791 800 MPPMGSPVIP  2.9 3
b Semaphorin 6A [precursor]
7 HDAC4 (HD4) P56524 343 352 LPLYTSPSLP  2.8 3
b Histone deacetylase 4
8 EVL (RNB6) Q9UI08 185 194 PPPPPVPPPP  2.7 83 Ena/vasodilator stimulated phosphoprotein-like protein
9 WASF1 (WAVE1, WAVE-1) Q92558 347 356 TPPPPVPPPP  2.7 132 Wiskott-Aldrich syndrome protein family member 1
10 YLPM1 (ZAP3, ZAP113) P49750 14 23 YPPPPVPPPP  2.7 115 YLP motif containing protein 1
aOnly the top 2,000 candidate peptides are shown in the Scansite Web site.
b3 represents not in the top 2,000 peptide list.
DOI: 10..1371/journal.pcbi.0020001.t003
Table 4. Comparison of Predictions of SPMFEP, Scansite, and iSPOT on 13 Known Interacting Proteins of the Abl SH3 Domain
Protein Accession ID SPMFEP Scansite iSPOT Description
3BP1_mouse [45] P55194 = 33 SH3 domain-binding protein 1
3BP2_mouse [46] Q06649 === SH3 domain-binding protein 2
EVL_human [35] Q9UI08 === Ena/vasodilator stimulated phosphoprotein-like protein (Ena/VASP-like protein)
NMDE4_human [47] O15399 == 3 Glutamate [NMDA] receptor subunit epsilon 4
P73_human [38] O15350 3 = 3 Tumor protein p73 (p53-like transcription factor) (p53-related protein)
PLS1_human [45] O15162 = 33 Phospholipid scramblase 1, type II membrane protein
WASF1_human [33] Q92558 === Wiskott-Aldrich syndrome protein family member 1 (WASP-family protein member
1) (Verprolin homology domain-containing protein 1)
PDE4D_human [49] Q08499 === cAMP-specific 39,59-cyclic phosphodiesterase 4D
Abi1_human [50] Q8IZP0 == 3 Abl-interactor 1 (Abelson interactor 1) (Abi-1) (Spectrin SH3 domain-binding pro-
tein 1) (Eps8 SH3 domain-binding protein) (Eps8 binding protein) (e3B1) (Nap1
binding protein) (Nap1BP) (Abl binding protein 4) (AblBP4)
CABL2_mouse [39] NP_665850 333 Cdk5 and Abl enzyme substrate 2 (interactor with cdk3 2) (ik3–2)
ENAH_mouse [51] Q03173 === Enabled protein homolog (NPC derived proline-rich protein 1) (NDPP-1)
SEM6D_mouse [35] NP_954711 333 Semaphorin 6D
CRK_human [52] P46108 = 33 Proto-oncogene C-crk
The corresponding binding peptides identified by SPMFEP, Scansite, and iSPOT can be found in Table S8.
DOI: 10.1371/journal.pcbi.0020001.t004
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Prediction of Abl SH3 Binding Partnerserrors due to insufﬁcient sampling of conformational space
and/or inaccurate free energy calculation can be cancelled.
There are two major hurdles of applying the VM method in
a high-throughput manner. First, the MD simulation and free
energy calculations are time-consuming. Second, a domain-
peptide complex structure is required. Given the fast pace of
advancement of computer power and structural genomics/
homology modeling, we believe that the VM method will
become more and more useful.
Materials and Methods
MD simulations. MD simulations were performed on the 15
binders and 20 non-binders of the Abl SH3 domain using the
AMBER 8 simulation package [19] and AMBER03 force ﬁeld [40]. The
amino acid sequences and the experimentally determined binding
afﬁnities of the 15 binders are shown in Table 1 [17]. Ten peptides, B1
to B10, were randomly selected from the human proteome and are
considered as non-binders (Table S1). Ten peptides, C1 to C10, do not
bind to the Abl SH3 domain but are Class I binders of other SH3
domains [12]: C1 and C2 bind to the Src SH3 domains, C3 and C4
bind to the Yes SH3 domain, and C5 to C10 bind to the Grb2 N-
terminal SH3 domain (Table S1). We chose the crystal structure of the
peptide APSYSPPPPP complexed with the Abl SH3 domain (Class I
binder and the PDB entry is 1bbz) [25] as the template and mutated it
to other peptides using the scap program [41]. The complex was
solvated in a rectangular box of about 3,000 TIP3P water molecules so
that the boundary of the box is at least 9 A ˚ away from any solute
atom. Counter-ions of Na
þ were placed based on the Columbic
potential to keep the whole system neutral. Particle Mesh Ewald
(PME) was employed to consider the long-range electrostatic
interactions [42]. Following 2,000 steps of minimization, a 1.2 ns (30
ps temperature increase from 10 8Kt o3 0 08Ka n d1 . 1 7n s
equilibration and data collection) MD simulation with a 2.0 fs time
step was performed on each complex. The SHAKE procedure was
employed to constrain hydrogen atoms [43] during MD and all heavy
atoms of SH3 were restrained using a 5 kcal mol
 1 A ˚  2 harmonic
force (see discussion in Supporting Information).
To determine the conformational energy of unbound peptide in
solvent, 2.0 ns MD simulation was conducted on each peptide. Each
peptide was solvated in a water box of about 1,600 water molecules,
which extended 10 A ˚ away from any peptide atom. 1,000 steps of
minimization were followed by a 2.0 ns MD simulation for
equilibration and data collection using the same set-up as described
above.
Free energy calculations using the MM/PBSA method. The binding
free energy is calculated as:
DGbind ¼ Gcomplex   Gprotein   Gligand
¼ DEMM þ DGPB þ DGSA   TDS ð1Þ
where DEMM is the molecular mechanics interaction energy between
the SH3 domain and the peptide, DGPB and DGSA are the electrostatic
and non-polar contributions to desolvation upon peptide binding,
respectively, and  TDS is the conformational entropy change. To
consider the conformational ﬂexibility of the peptide, we ran two
separate MD simulations on the complex and the free peptide to
calculate the binding free energy [16].
DEMM was calculated using the sander program in AMBER 8 [19].
DGPB was calculated using the pbsa program in AMBER 8. The grid
size used to solve the Poisson-Boltzmann equation was 0.5 A ˚ , and the
values of interior dielectric constant and exterior dielectric constant
were set to 1 and 80, respectively (the inﬂuence of the interior
dielectric constant value to the free energy calculation is discussed in
Supporting Information). DGSA was estimated from the surface area
[16, 44]. The peptide-SH3 interaction energies were calculated from
150 snapshots taken from 300 ps to 1.2 ns MD simulation trajectories
of the complex. 160 snapshots taken from 400 ps to 2.0 ns MD
simulations on the unbound peptides were used to calculate the
conformational energy change for the peptides.
The normal mode analysis was performed to estimate the vibra-
tional component of the entropy using the nmode program in AMBER
8 [19]. In the absence of solvent, the structures (complex, SH3, and
peptide) were minimized with no cutoff for non-bonded interactions,
by using conjugate gradient and then Newton-Raphson minimizations
until the root mean square of the elements of gradient vector was less
than 5310
 5 kcal/mol. Then, normal mode calculations were carried
out with no cutoff for non-bonded interactions. A distance-depend-
ent dielectric constant (e¼4Rij) was used to mimic solvent screening.
Frequencies of the vibrational modes were computed at 300K for
these minimized structures and using a harmonic approximation of
the energies. Due to the high computational demand, only 25
snapshots taken from MD were used to estimate TDS.
The VM method. To investigate the preference of residues at each
position, systematic single point mutation was performed on the
peptide. The peptide APSYSPPPPP in the crystal structure 1bbz was
used as the template. Each residue of the peptide was mutated to the
other 19 residues using the scap program [41]. Minimization, MD
simulations, and MM/PBSA calculations were performed on all 190
mutated complexes, as well as on the free peptides using the same set-
up described above. Assuming mutating a single residue of the
peptide did not signiﬁcantly change the peptide conformation, we
did not include the conformational entropy in the comparison of 20
residues at each position.
Single point mutation free energy proﬁle and database scan. The
SPMFEP is a 10320 matrix, which represents the difference between
the binding free energies of the mutated peptides and the template
peptide APSYSPPPPP (Table 2). SPMFEP can be used as a position
speciﬁc scoring matrix. The score of each peptide is calculated as: P10
i¼1 MS;idðS;SiÞ, where MS,i is the score of the amino acid S at i
th
position in the SPMFEP and Si is the amino acid at the i
th position of
the peptide. All ten-residue-long peptides in the SWISS-PROT
database (release 46.4) were scored using the SPMFEP. The Perl
script used for the database scan is available upon request.
Supporting Information
Figure S1. The Correlations between the Experimental and Calcu-
lated Relative Binding Free Energies Using an Interior Dielectric
Constant of 2
Found at DOI: 10.1371/journal.pcbi.0020001.sg001 (249 KB TIF).
Figure S2. The Superposition of 23 Snapshots Extracted from the MD
Trajectory from 0.1 ns to 1.2 ns
The structure of SH3 shown here was extracted from the snapshot at
0.1 ns. The residues at P3,P  3,P  4,P  5, and P 6 of the peptide are
colored in red and other residues are colored according to residue
type deﬁned in Insight II.
Found at DOI: 10.1371/journal.pcbi.0020001.sg002 (2.9 MB TIF).
Figure S3. The Fluctuations of the Free Energy Components
PB represents the polar contribution to the solvation free energy
(DGPB). Electrostatic means the electrostatic interaction between the
peptide and the SH3 domain (DEele), and van de Waals means the van
de Waals interactions between the peptide and the SH3 domain
(DEvdw).
Found at DOI: 10.1371/journal.pcbi.0020001.sg003 (358 KB TIF).
Figure S4. The Interactions between Peptide FGTYPPPLPP and the
Abl SH3 Domain
Two residues, Trp36 and Trp47, are shown in stick, and the peptide is
shown in ball-and-stick.
Found at DOI: 10.1371/journal.pcbi.0020001.sg004 (942 KB TIF).
Protocol S1. The MM/PBSA Calculations Protocols and the
Conformational Changes of Ligands in Peptide Binding
Found at DOI: 10.1371/journal.pcbi.0020001.sd001 (42 KB DOC).
Table S1. The Energetic Components and Binding Afﬁnities for 20
Non-Binders (kcal/mol)
Found at DOI: 10.1371/journal.pcbi.0020001.st001 (66 KB DOC).
Table S2. The Energetic Components and Binding Afﬁnities for the
15 Peptide Ligands of the Abl SH3 Domain Using Interior Dielectric
Constant of 2 (kcal/mol)
Found at DOI: 10.1371/journal.pcbi.0020001.st002 (56 KB DOC).
Table S3. The Binding Free Energies for 20 Peptides Mutated at
Position P 5 (kcal/mol)
Found at DOI: 10.1371/journal.pcbi.0020001.st003 (63 KB DOC).
Table S4. The Binding Free Energies for 20 Peptides Mutated at
Position P 3 (kcal/mol)
Found at DOI: 10.1371/journal.pcbi.0020001.st004 (62 KB DOC).
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Prediction of Abl SH3 Binding PartnersTable S5. The Binding Free Energies for 20 Peptides Mutated at
Position P0 (kcal/mol)
Found at DOI: 10.1371/journal.pcbi.0020001.st005 (61 KB DOC).
Table S6. The Binding Free Energies for 20 Peptides Mutated at
Position P3 (kcal/mol)
Found at DOI: 10.1371/journal.pcbi.0020001.st006 (65 KB DOC).
Table S7. The Contribution of Each Residue in Peptide APSYSPPPPP
to the SH3 Binding (kcal/mol)
Found at DOI: 10.1371/journal.pcbi.0020001.st007 (57 KB DOC).
Table S8. The High-Rank Peptides Selected by PMFEP, Scansite, and
iSPOT in 13 Abl SH3-Binding Proteins
Found at DOI: 10.1371/journal.pcbi.0020001.st008 (54 KB DOC).
Table S9. The Top 600 Sequences Found in Human Proteins from
Database Search
Found at DOI: 10.1371/journal.pcbi.0020001.st009 (643 KB DOC).
Accession Numbers
The Swiss-Prot and TrEMBL (http://www.expasy.org/sprot) accession
numbers for the genes and gene products discussed in this paper are:
1bb9 (1bb9), 1bbz (CAB04591), 1cka (CAA18266), 1gbq (1gbqa),
3BP1_human (Q9Y3L3), 3BP1_mouse (P55194), 3BP2 (P78314),
3BP2_mouse (Q06649), AD08 (P78325), AT19 (Q8TE59), CABL2_-
human (NP_665850), DYN2 (P50570), EVL (Q9UI08), P73_human
(O15350), PRL3 (P02814), RBMG (Q9UPN6), RX (Q9Y2V3), SCA3
(O14828), SEM6A (Q9H2E6), SEM6D (Q76KF3), SEM6D_mouse
(NP_954711), SEP4 (O43236), TACT (P40200), WASF1 (Q92558),
and WASF4 (Q8IV90).
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